Brandywine Global Investment Management’s CorMedix CRMD Stock Holding History

Brandywine Global Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.09M	Buy	+179,980	New	+$1.99M	0.01%	469

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Brandywine Global Investment Management's CRMD Position: Q4 2025 in Review

Brandywine Global Investment Management opened a new position in CorMedix (CRMD) in Q4 2025: 179,980 shares worth $2.09M. The stake represents 0.01% of the portfolio and ranks #469 among its holdings.

198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

Brandywine Global Investment Management held 179,980 shares of CorMedix worth $2.09M as of Q4 2025.
CorMedix was a new Brandywine Global Investment Management position in Q4 2025.
CorMedix made up 0.01% of Brandywine Global Investment Management's portfolio in Q4 2025, its #469 holding.
198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.